new studies on glp 1 Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine Issue 42: GLP-1 RA Drug

A separate prospective study of approximately 200 adults (Haines et al., presented at the Endocrine Society, 2025) combining GLP-1 therapy with structured protein guidance and resistance training education found participants lost about 13% body weight but only about 3% muscle mass on average

[54] The drug decreases mimicks the hormone glucagon-like peptide-1 (GLP-1), an incretin

But she said her clinic has already begun preparing by adding providers and identifying patients who may qualify for the program

All but two of the RCTs included a placebo

doi: 10.1016/j.cmet.2006.01.004 3 PykeCHellerRSKirkRKrskovCReedtz-RungeSKaastrupP.GLP-1 receptor localization in monkey and human tissue: Novel distribution revealed with extensively validated monoclonal antibody